| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802539301010 | 253930101 | SOMAVERT PS.INJ.SOL 10MG/VIAL BTx 30(VIAL)+30 (VIAL x 8ML SOLV) (VIALX8ML SOLV) | 1655.96 | 1680.80 | 1848.46 |
| 05/2018 | 2802539301027 | 253930102 | SOMAVERT PS.INJ.SOL 10MG/VIAL BTx 30 VIALS+30 PF.SYRS x 1ML SOLV | 1655.96 | 1680.80 | 1848.46 |
| 05/2018 | 2802539302017 | 253930201 | SOMAVERT PS.INJ.SOL 15MG/VIAL BTx 30(VIAL)+30(VIAL x 8ML SOLV) X8ML SOLV) | 2471.77 | 2508.84 | 2725.85 |
| 05/2018 | 2802539302024 | 253930202 | SOMAVERT PS.INJ.SOL 15MG/VIAL BTx 30 VIALS+30 PF.SYRS x 1ML SOLV | 2471.77 | 2508.84 | 2725.85 |
| 05/2018 | 2802539303014 | 253930301 | SOMAVERT PS.INJ.SOL 20MG/VIAL BTx30 (VIAL)+30(VIAL x 8MLSOLV) X8MLSOLV) | 3276.59 | 3325.74 | 3595.79 |
| 05/2018 | 2802539303038 | 253930303 | SOMAVERT PS.INJ.SOL 20MG/VIAL BTx 30 VIALS+30 PF.SYRS x 1ML SOLV | 3276.59 | 3325.74 | 3595.79 |
| 05/2018 | 2802539304042 | 253930404 | SOMAVERT PS.INJ.SOL 25MG/VIAL BTx 30 VIALS+30 PF.SYRS x 1ML SOLV | 4495.91 | 4563.35 | 4933.90 |
| 05/2018 | 2802539305049 | 253930504 | SOMAVERT PS.INJ.SOL 30MG/VIAL BTx 30 VIALS+30 PF.SYRS x 1ML SOLV | 5395.09 | 5476.02 | 5920.67 |
Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.
Somavert selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of endogenous GH. This leads to the normalization of serum IGF-1 levels.
~6 days
* 7 L
* 36 - 28 mL/h [SC doses ranging from 10 to 20 mg/day]